Form 4: Bernd Brust Reports Stock Transactions

Bernd Brust, CEO of Maravai Lifesciences Holdings, Inc., reported transactions involving Class A Common Stock, including shares withheld for tax obligations.

Summary

• Bernd Brust, Chief Executive Officer and Director of Maravai Lifesciences Holdings, Inc. (MRVI), reported a transaction on July 8, 2026.
• The transaction involved 29,250 shares of Class A Common Stock, acquired at a price of $5.92 per share.
• These shares were withheld to satisfy tax withholding obligations related to the vesting of restricted stock unit awards.
• Following this transaction, Brust directly beneficially owns 1,619,749 shares of Class A Common Stock.
• Additionally, Brust indirectly beneficially owns 466,771 shares through The Bernd Brust Management Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions related to equity compensation and tax obligations, without indicating significant changes in beneficial ownership or company performance.

Positives

• Vesting of restricted stock units indicates continued equity-based compensation for management.
• Direct beneficial ownership of a significant number of shares (1,619,749) suggests alignment with shareholder interests.

Negatives

• Withholding of shares for tax obligations represents a reduction in the net shares received by the reporting person.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not typically contain strategic or financial performance information. This filing reflects routine equity compensation management by a key executive.

Stakeholder Impact

• Shareholders: The transaction reflects standard equity compensation practices and does not indicate a change in the reporting person's overall beneficial ownership that would significantly impact shareholder value.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Maravai Lifesciences, MRVI, Bernd Brust, Class A Common Stock, Restricted Stock Units, Tax Withholding